Skip to content
Clinical Trials – home
Research site

Klaipeda University Hospital

Lithuania Liepojos str. 45, LT-92288 Klaipeda, Lithuania

  • Acute coronary syndrome · Atrial fibrillation
  • Adult patients

About Specializations

Klaipeda University Hospital in Klaipeda, Lithuania specialises in clinical trials of conditions such as Acute coronary syndrome, Atrial fibrillation, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Klaipeda University Hospital, clinical research is focused on cardiovascular diseases, with studies centered on major conditions such as atrial fibrillation and acute coronary syndrome. The trials are designed to assess new treatment options that may help lower the risk of serious heart-related events and improve prevention strategies for patients with high cardiovascular risk.

  • Research on atrial fibrillation is examining ways to prevent stroke and other cardioembolic complications.
  • Studies in acute coronary syndrome are evaluating approaches to reduce recurrent cardiovascular events after a heart attack.
  • The overall goal is to test whether a new therapy can improve protection against major outcomes such as stroke, myocardial infarction, and cardiovascular death.

This small but focused portfolio reflects the hospital’s involvement in advancing cardiovascular care through trials that compare treatment effectiveness and support better long-term outcomes for patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Liepojos str. 45LT-92288 KlaipedaLithuania
Recruiting now
no trials
Conditions studied
2

More sites in KlaipedaLithuania

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Atrial fibrillation

Not recruiting
Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.